“Plaintiffs have taken a position that is fundamentally ideological, not scientific. If the judge agrees and grants a nationwide preliminary injunction, patients across the country would lose access to the medication used for patients experiencing miscarriages, choosing medication abortions, experiencing bleeding or hemorrhaging during certain serious pregnancy complications, being treated for Cushing’s Syndrome and other existing and growing treatments not related to pregnancy. The lawsuit claims that the FDA’s initial approval process for mifepristone was inappropriate and that the agency didn’t protect the health and safety of women and girls. The Alliance for Hippocratic Medicine filed the suit on behalf of itself and member groups such as the Catholic Medical Association, the Christian Medical and Dental Associations, and others that oppose abortion.

A federal judge in Texas is holding a hearing Wednesday in a lawsuit that challenges the approval of the drug, by the Food and Drug Administration (FDA), more than 20 years ago.

Digital master 780 free download